David Pacitti - 13 Mar 2026 Form 4/A - Amendment Insider Report for AVANOS MEDICAL, INC. (AVNS)

Reporting relationship: Chief Executive Officer
Issuer ticker: AVNS
Reported as of: 13 Mar 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 01 Apr 2026, 15:22:02 UTC
Original report date: 01 Apr 2026
Prior SEC filing: 08 Aug 2025
Next SEC filing: 16 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ John Hurley, as attorney-in-fact for David Pacitti

Key filing fact

David Pacitti filed Form 4/A - Amendment for AVANOS MEDICAL, INC. (AVNS) on 01 Apr 2026.

Key facts

This page summarizes David Pacitti's Form 4/A - Amendment filing for AVANOS MEDICAL, INC. (AVNS).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 01 Apr 2026, 15:22.

Change

Previous filing in this sequence was filed on 08 Aug 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001722733 Primary reporting owner

Pacitti David

Relationship: Chief Executive Officer
Address: 5405 WINDWARD PKWY, ALPHARETTA
Signature: /s/ John Hurley, as attorney-in-fact for David Pacitti
Signature date: 01 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVNS transaction

Common Stock

Award

Transaction value
Shares: +101,341
Change %: +42%
Price: $0.000000^*
Shares after: 343,388
Date: 13 Mar 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVNS transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +239,354
Change %
Price: $0.000000^*
Shares after: 239,354
Date: 13 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 239,354
Exercise price: $13.69
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest 1/3 on March 13, 2027, 1/3 on March 13, 2028 and 1/3 on March 13, 2029. Each TRSU is the economic equivalent of one share of Common Stock.

Footnote F2

The award will vest 30% on March 13, 2027, 30% on March 13, 2028 and 40% on March 13, 2029.

SEC remarks

This Form 4/A is being filed to correct a Form 4/A filed on April 1, 2026 that erroneously added to the number of stock options issued to the Reporting Person on March 13, 2026 pursuant to the Issuer's 2021 Long-Term Incentive Plan, as amended. The number of stock options originally reported in the Form 4 filed on March 17, 2026 was correct.